Cited by 63Inflammasome and immune disordersAntifungal resistance and susceptibilityIL-33, ST2, and ILC Pathways

Targeting the Aryl Hydrocarbon Receptor With Indole-3-Aldehyde Protects From Vulvovaginal Candidiasis via the IL-22-IL-18 Cross-Talk

Open access
Borghi, Monica, Pariano, Marilena, Solito, Valentina, Puccetti, Matteo, Bellet, Marina M., Stincardini, Claudia, Renga, Giorgia, Vacca, Carmine +5 more·2019·Frontiers in Immunology

Abstract

Vulvovaginal candidiasis (VVC) is a common mucosal infection caused by Candida spp., most frequently by Candida albicans, which may become recurrent and severely impacting the quality of life of susceptible women. Although it is increasingly being recognized that mucosal damage is mediated by an exaggerated inflammatory response, current therapeutic approaches are only based on antifungals that may relieve the symptomatology, but fail to definitely prevent recurrences. The unrestrained activation of the NLRP3 inflammasome with continuous production of IL-1β and recruitment of neutrophils is recognized as a pathogenic factor in VVC. We have previously shown that IL-22 is required to dampen pathogenic inflammasome activation in VVC via the NLRC4/IL-1Ra axis. However, IL-22 also regulates IL-18, a product of the inflammasome activity that regulates IL-22 expression. Here we describe a cross-regulatory circuit between IL-18 and IL-22 in murine VVC that is therapeutically druggable. We found that IL-18 production was dependent on IL-22 and NLRC4, and that IL-18, in turn, contributes to IL-22 activity. Like in IL-22 deficiency, IL-18 deficiency was associated with an increased susceptibility to VVC and unbalanced Th17/Treg response, suggesting that IL-18 can regulate both the innate and the adaptive responses to the fungus. Administration of the microbial metabolite indole-3-aldehyde, known to stimulate the production of IL-22 via the aryl hydrocarbon receptor (AhR), promoted IL-18 expression and protection against Candida infection. Should low levels of IL-18 be demonstrated in the vaginal fluids of women with recurrent VVC, targeting the AhR/IL-22/IL-18 pathway could be exploited for future therapeutic approaches in VVC. This study suggests that a deeper understanding of the mechanisms regulating inflammasome activity may lead to the identification of novel targets for intervention in VVC.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2019.02364

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Evidence suggests vaginal indoles, including ILA and indole-3-aldehyde, activate the aryl hydrocarbon receptor (AhR) to modulate immune responses and provide protection against vulvovaginal candidiasis.

    “Evidence suggests that vaginal indoles, including ILA and indole-3-aldehyde, activate the aryl hydrocarbon receptor (AhR) to modulate immune responses and provide protection against vulvovaginal candidiasis [61, 62].”

    From Women's health is a team effort: probiogenomics supports the development of a multi-species vaginal probiotic (2026) · cites this paper as [62]

    The Introduction and Results report that indole-3-aldehyde acts through AhR, alters IL-22/IL-18 responses, and protects mice against vulvovaginal candidiasis. The passages do not establish the same effects for ILA, and the protection demonstrated here is in a murine model, not in humans. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

1 of the 35 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Borghi, M., Pariano, M., Solito, V., Puccetti, M., Bellet, M. M., Stincardini, C., Renga, G., Vacca, C., Sellitto, F., Mosci, P., Brancorsini, S., Romani, L., & Costantini, C.
Affiliations
University of Perugia (IT)
Corresponding author
  • Borghi, Monica
  • Costantini, Claudio
Venue
Frontiers in Immunology
Published
2019-10-11
Volume
10
Pages
2364-2364
ISSN
1664-3224 (ISSN-L)
OpenAlex
W2979758115
Cited by
63
References
35
Citations by year
2026: 14 · 2025: 8 · 2024: 10 · 2023: 6 · 2022: 8 · 2021: 14 · 2020: 3
FWCI
2.07
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Immunology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Seventh Framework Programme
  • Horizon 2020
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
Keywords
vaginal candidiasis, Candida albicans, aryl hydrocarbon receptor, indole-3-carboxaldehyde, IL-22, IL-18, NLRP3 inflammasome, NLRC4, IL-1β, Th17/Treg balance, vaginal inflammation, recurrent candidiasis, microbial metabolites
MeSH terms
NLR Family, Pyrin Domain-Containing 3 Protein, Interleukin-22, Animals, Candida albicans, Candidiasis, Vulvovaginal, Female, Indoles, Interleukins, Signal Transduction, Receptors, Aryl Hydrocarbon, Mice, Knockout, Interleukin-18, T-Lymphocytes, Regulatory, Mice, Basic Helix-Loop-Helix Proteins, Th17 Cells, Inflammasomes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review